Search for: "Actavis plc" Results 61 - 70 of 70
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
FDA Once Again Departs From Conventional Bioequivalence Metrics and Sets Partial AUC Parameters for Generic ADDERALL XR
24 Jun 2012, 11:40 pm by FDABlog HPM
  In April 2010, Actavis submitted a citizen petition (Docket No. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Court Report
8 Apr 2012, 8:51 pm by Patent Docs
Actavis Inc. et al. 1:12-cv-00323;... [read post]
Patent Docs - http://www.patentdocs.org/
We Don't Recall
11 Aug 2011, 1:09 pm by Bexis
Actavis Totowa, LLC, 2010 WL [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Pharma & Biotech Global Week in Review 30 March 2011 from IP Think Tank
29 Mar 2011, 9:19 pm by Marie Louise
(The IP Factor) Products Actonel (Risedronate) – US: Warner Chilcott files patent infringement complaint against Mylan in response to Para IV certification (Patent Docs) Actos (Pioglitazone) – US: Takeda files patent infringement suit against Apotex following Para IV challenge (Patent Docs) Antara (Fenofibrate) – US: Lupin files patent infringement lawsuits against Mylan, Apotex following Para IV certification (Patent Docs) Drospirenone, Ethinylestradiol – EU: Inventive step,… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Total Recall
28 Sep 2009, 1:31 am
BOC Group PLC, 2001 WL 477237, at *5 (N.D. [read post]
For the Defense - http://forthedefense.org/ftd.aspx
Total Recall
28 Sep 2009, 1:31 am
BOC Group PLC, 2001 WL 477237, at *5 (N.D. [read post]
For the Defense - http://forthedefense.org/ftd.aspx
Total Recall
28 Sep 2009, 1:31 am
BOC Group PLC, 2001 WL 477237, at *5 (N.D. [read post]
For the Defense - http://forthedefense.org/ftd.aspx
Total Recall
24 Sep 2009, 5:09 am
BOC Group PLC, 2001 WL 477237, at *5 (N.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Teva's Budeprion XL Will Get Another Safety And Efficacy Review By FDA
23 Sep 2008, 9:34 pm
. -- is as safe and effective as Wellbutrin XL -- made by Canada's Biovail Corp. and sold by GlaxoSmithKline PLC. [read post]
Drug Injury Watch - http://www.drug-injury.com/druginjurycom/
IP Think Tank Global Week in Review - 1 August 2008
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog